Inactive Instrument

Lattice Biologics Ltd. Stock Toronto S.E.

Equities

LBL.H

CA5184101056

Medical Equipment, Supplies & Distribution

Sales 2019 2.19M 2.99M Sales 2020 2.46M 3.37M Capitalization 4.74M 6.48M
Net income 2019 -1M -1.37M Net income 2020 -1M -1.37M EV / Sales 2019 1.74 x
Net Debt 2019 2.12M 2.89M Net Debt 2020 3.08M 4.2M EV / Sales 2020 3.17 x
P/E ratio 2019
-1.67 x
P/E ratio 2020
-2.56 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 79.69%
More Fundamentals * Assessed data
Dynamic Chart
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.
More about the company